Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Upgrades

According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from In-Line to Outperform. In the third quarter, BioCryst Pharmaceuticals showed an EPS of $0.23, compared to $0.33 from the year-ago quarter. The current stock performance of BioCryst Pharmaceuticals shows a 52-week-high of $19.99 and a 52-week-low of $7.61. Moreover, at the end of the last trading period, the closing price was at $11.86.
According to B of A Securities, the prior rating for KKR & Co Inc (NYSE:KKR) was changed from Neutral to Buy. In the third quarter, KKR & Co showed an EPS of $0.93, compared to $1.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $75.19 and a 52-week-low of $41.77. KKR & Co closed at $49.47 at the end of the last trading period.
Baird upgraded the previous rating for Premier Inc (NASDAQ:PINC) from Neutral to Outperform. For the first quarter, Premier had an EPS of $0.52, compared to year-ago quarter EPS of $0.64. At the moment, the stock has a 52-week-high of $41.42 and a 52-week-low of $31.00. Premier closed at $31.77 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Abiomed Inc (NASDAQ:ABMD) was changed from Underweight to Equal-Weight. For the second quarter, Abiomed had an EPS of $1.30, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $381.99 and a 52-week-low of $219.84. Abiomed closed at $377.82 at the end of the last trading period.
Raymond James upgraded the previous rating for IPG Photonics Corp (NASDAQ:IPGP) from Underperform to Market Perform. In the third quarter, IPG Photonics showed an EPS of $1.47, compared to $1.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $176.63 and a 52-week-low of $79.88. IPG Photonics closed at $85.48 at the end of the last trading period.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

See all analyst ratings upgrades.

Downgrades

According to B of A Securities, the prior rating for Catalent Inc (NYSE:CTLT) was changed from Buy to Neutral. In the first quarter, Catalent showed an EPS of $0.34, compared to $0.71 from the year-ago quarter. The stock has a 52-week-high of $128.26 and a 52-week-low of $47.60. At the end of the last trading period, Catalent closed at $49.53.
For Twilio Inc (NYSE:TWLO), B of A Securities downgraded the previous rating of Buy to Underperform. For the second quarter, Twilio had an EPS of $0.11, compared to year-ago quarter EPS of $0.11. The current stock performance of Twilio shows a 52-week-high of $266.74 and a 52-week-low of $62.10. Moreover, at the end of the last trading period, the closing price was at $75.08.
Compass Point downgraded the previous rating for Centerspace (NYSE:CSR) from Buy to Neutral. Centerspace earned $1.15 in the third quarter, compared to $0.98 in the year-ago quarter. The current stock performance of Centerspace shows a 52-week-high of $111.48 and a 52-week-low of $62.79. Moreover, at the end of the last trading period, the closing price was at $67.06.
According to Mizuho, the prior rating for Avista Corp (NYSE:AVA) was changed from Buy to Neutral. In the third quarter, Avista showed an EPS of $0.08, compared to $0.20 from the year-ago quarter. The current stock performance of Avista shows a 52-week-high of $46.90 and a 52-week-low of $36.32. Moreover, at the end of the last trading period, the closing price was at $37.66.
According to Oppenheimer, the prior rating for Blueprint Medicines Corp (NASDAQ:BPMC) was changed from Outperform to Perform. For the third quarter, Blueprint Medicines had an EPS of $2.23, compared to year-ago quarter EPS of $2.00. The current stock performance of Blueprint Medicines shows a 52-week-high of $110.23 and a 52-week-low of $43.46. Moreover, at the end of the last trading period, the closing price was at $48.24.
Credit Suisse downgraded the previous rating for Nasdaq Inc (NASDAQ:NDAQ) from Outperform to Neutral. In the third quarter, Nasdaq showed an EPS of $0.68, compared to $0.59 from the year-ago quarter. The current stock performance of Nasdaq shows a 52-week-high of $70.29 and a 52-week-low of $46.77. Moreover, at the end of the last trading period, the closing price was at $62.35.
According to Deutsche Bank, the prior rating for Abiomed Inc (NASDAQ:ABMD) was changed from Buy to Hold. In the second quarter, Abiomed showed an EPS of $1.30, compared to $1.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $381.99 and a 52-week-low of $219.84. Abiomed closed at $377.82 at the end of the last trading period.
According to Deutsche Bank, the prior rating for Ecolab Inc (NYSE:ECL) was changed from Buy to Hold. In the third quarter, Ecolab showed an EPS of $1.30, compared to $1.38 from the year-ago quarter. The current stock performance of Ecolab shows a 52-week-high of $237.38 and a 52-week-low of $136.94. Moreover, at the end of the last trading period, the closing price was at $142.98.
According to B. Riley Securities, the prior rating for Semler Scientific Inc (NASDAQ:SMLR) was changed from Buy to Neutral. In the third quarter, Semler Scientific showed an EPS of $0.46, compared to $0.51 from the year-ago quarter. At the moment, the stock has a 52-week-high of $93.98 and a 52-week-low of $27.02. Semler Scientific closed at $43.00 at the end of the last trading period.
Wolfe Research downgraded the previous rating for Cleveland-Cliffs Inc (NYSE:CLF) from Peer Perform to Underperform. Cleveland-Cliffs earned $0.29 in the third quarter, compared to $2.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.04 and a 52-week-low of $12.90. Cleveland-Cliffs closed at $13.35 at the end of the last trading period.
According to Truist Securities, the prior rating for SeaSpine Holdings Corp (NASDAQ:SPNE) was changed from Buy to Hold. In the third quarter, SeaSpine Holdings showed an EPS of $0.42, compared to $0.48 from the year-ago quarter. The current stock performance of SeaSpine Holdings shows a 52-week-high of $14.26 and a 52-week-low of $5.48. Moreover, at the end of the last trading period, the closing price was at $6.46.
According to Keybanc, the prior rating for Avista Corp (NYSE:AVA) was changed from Sector Weight to Underweight. In the third quarter, Avista showed an EPS of $0.08, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $46.90 and a 52-week-low of $36.32. At the end of the last trading period, Avista closed at $37.66.

See all analyst ratings downgrades.

Initiations

With a Hold rating, WestPark Capital initiated coverage on Aeva Technologies Inc (NYSE:AEVA). The price target seems to have been set at $3.00 for Aeva Technologies. For the second quarter, Aeva Technologies had an EPS of $0.13, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $8.07 and a 52-week-low of $1.75. Aeva Technologies closed at $1.89 at the end of the last trading period.
WestPark Capital initiated coverage on Luminar Technologies Inc (NASDAQ:LAZR) with a Buy rating. The price target for Luminar Technologies is set to $14.00. The current stock performance of Luminar Technologies shows a 52-week-high of $18.16 and a 52-week-low of $5.61. Moreover, at the end of the last trading period, the closing price was at $8.25.
With a Hold rating, WestPark Capital initiated coverage on AEye Inc (NASDAQ:LIDR). The price target seems to have been set at $1.00 for AEye. In the second quarter, AEye showed an EPS of $0.13, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.33 and a 52-week-low of $0.80. AEye closed at $0.89 at the end of the last trading period.
With a Neutral rating, Macquarie initiated coverage on Check Point Software Technologies Ltd (NASDAQ:CHKP). The price target seems to have been set at $129.00 for Check Point Software. For the third quarter, Check Point Software had an EPS of $1.77, compared to year-ago quarter EPS of $1.65. The stock has a 52-week-high of $149.62 and a 52-week-low of $107.54. At the end of the last trading period, Check Point Software closed at $129.82.
With an Overweight rating, Cantor Fitzgerald initiated coverage on Sorrento Therapeutics Inc (NASDAQ:SRNE). The price target seems to have been set at $5.00 for Sorrento Therapeutics. Sorrento Therapeutics earned $0.54 in the second quarter, compared to $0.57 in the year-ago quarter. The stock has a 52-week-high of $4.99 and a 52-week-low of $1.15. At the end of the last trading period, Sorrento Therapeutics closed at $1.58.
With a Buy rating, B of A Securities initiated coverage on Denali Therapeutics Inc (NASDAQ:DNLI). The price target seems to have been set at $40.00 for Denali Therapeutics. Denali Therapeutics earned $0.48 in the second quarter, compared to $0.50 in the year-ago quarter. The stock has a 52-week-high of $47.47 and a 52-week-low of $20.24. At the end of the last trading period, Denali Therapeutics closed at $28.96.
Macquarie initiated coverage on Palo Alto Networks Inc (NASDAQ:PANW) with a Neutral rating. The price target for Palo Alto Networks is set to $185.00. Palo Alto Networks earned $0.80 in the fourth quarter, compared to $0.53 in the year-ago quarter. The stock has a 52-week-high of $213.63 and a 52-week-low of $140.52. At the end of the last trading period, Palo Alto Networks closed at $170.77.
With a Neutral rating, Macquarie initiated coverage on Okta Inc (NASDAQ:OKTA). The price target seems to have been set at $60.00 for Okta. Okta earned $0.10 in the second quarter, compared to $0.11 in the year-ago quarter. The stock has a 52-week-high of $226.49 and a 52-week-low of $47.54. At the end of the last trading period, Okta closed at $55.00.
With a Neutral rating, Macquarie initiated coverage on Cloudflare Inc (NYSE:NET). The price target seems to have been set at $60.00 for Cloudflare. Cloudflare earned $0.00 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $132.45 and a 52-week-low of $38.96. At the end of the last trading period, Cloudflare closed at $55.58.
Macquarie initiated coverage on Microsoft Corp (NASDAQ:MSFT) with a Neutral rating. The price target for Microsoft is set to $234.00. In the first quarter, Microsoft showed an EPS of $2.35, compared to $2.27 from the year-ago quarter. At the moment, the stock has a 52-week-high of $338.00 and a 52-week-low of $219.13. Microsoft closed at $228.17 at the end of the last trading period.
With an Outperform rating, Macquarie initiated coverage on HubSpot Inc (NYSE:HUBS). The price target seems to have been set at $355.00 for HubSpot. At the moment, the stock has a 52-week-high of $659.24 and a 52-week-low of $245.03. HubSpot closed at $290.18 at the end of the last trading period.
With a Neutral rating, Macquarie initiated coverage on Snowflake Inc (NYSE:SNOW). The price target seems to have been set at $173.00 for Snowflake. In the second quarter, Snowflake showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. The current stock performance of Snowflake shows a 52-week-high of $344.00 and a 52-week-low of $110.27. Moreover, at the end of the last trading period, the closing price was at $159.50.
Macquarie initiated coverage on Workday Inc (NASDAQ:WDAY) with a Neutral rating. The price target for Workday is set to $170.00. In the second quarter, Workday showed an EPS of $0.83, compared to $1.23 from the year-ago quarter. The current stock performance of Workday shows a 52-week-high of $272.50 and a 52-week-low of $134.10. Moreover, at the end of the last trading period, the closing price was at $151.60.
Macquarie initiated coverage on Zscaler Inc (NASDAQ:ZS) with a Neutral rating. The price target for Zscaler is set to $155.00. Zscaler earned $0.25 in the fourth quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Zscaler shows a 52-week-high of $323.55 and a 52-week-low of $125.12. Moreover, at the end of the last trading period, the closing price was at $150.39.
Bernstein initiated coverage on Cronos Group Inc (NASDAQ:CRON) with a Market Perform rating. The price target for Cronos Group is set to $3.00. Cronos Group earned $0.05 in the second quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $4.31 and a 52-week-low of $2.57. At the end of the last trading period, Cronos Group closed at $3.23.
Bernstein initiated coverage on Canopy Growth Corp (NASDAQ:CGC) with an Underperform rating. The price target for Canopy Gwth is set to $1.50. Canopy Gwth earned $0.71 in the first quarter, compared to $0.52 in the year-ago quarter. The current stock performance of Canopy Gwth shows a 52-week-high of $9.64 and a 52-week-low of $2.13. Moreover, at the end of the last trading period, the closing price was at $3.49.
Bernstein initiated coverage on Tilray Brands Inc (NASDAQ:TLRY) with a Market Perform rating. The price target for Tilray Brands is set to $3.90. In the first quarter, Tilray Brands showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $9.08 and a 52-week-low of $2.65. At the end of the last trading period, Tilray Brands closed at $3.82.
For Legend Biotech Corp (NASDAQ:LEGN), Evercore ISI Group initiated coverage, by setting the current rating at Outperform. Legend Biotech earned $0.24 in the first quarter, compared to $0.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $57.67 and a 52-week-low of $30.75. Legend Biotech closed at $51.01 at the end of the last trading period.
Truist Securities initiated coverage on OneSpaWorld Holdings Ltd (NASDAQ:OSW) with a Buy rating. The price target for OneSpaWorld Holdings is set to $12.00. In the third quarter, OneSpaWorld Holdings showed an EPS of $0.13, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $10.99 and a 52-week-low of $6.80. OneSpaWorld Holdings closed at $8.97 at the end of the last trading period.

See all analyst ratings initiations.